Answers are grounded in this paper and cite their sources.
Our data suggest that in a real-life cohort of HF patients, the addition of ST2 and NTproBNP substantially improves the risk stratification for death beyond that of a model that is based only on established mortality risk factors.
No takes yet. Share an insight, caveat, or question.
Bayés‐Genís et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: